A survey in Portugal [26] carried out in 2020 showed that 44.2% of men had been submitted to PCa screening; 13.8% received only DRE, 12.2% received only PSA test, and 18.2% received both DRE and PSA tests. This evidence concerns the gene KLK3 and posterior cortical atrophy.